Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Hisun Pharma Signs Up GeneriCo to Market its Products in US

publication date: Sep 13, 2016
Zhejiang Hisun Pharma engaged GeneriCo, a specialty generic drug company based in Saint Louis, to be its sales and marketing partner in the US. Hisun has 20 generic drug applications pending with the US FDA. GeneriCo, a three-year old company, is developing several difficult-to-make generic drugs for US approval, but does not seem to be marketing any drugs at the moment. However, Tom Brya, President and CEO of GeneriCo, said the Hisun deal will allow GeneriCo to "extend and enhance" its commercialization programs. More details....

Stock Symbol: (SHA: 600267)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital